|
Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) Clinical Trials Information presented on Clinical Trials Search is not intended to be a substitute for qualified health advice, trips or treatment by using a genuine doctor. We aren't doctors. Always consult your mD on Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) Clinical research trials and Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) health trials take place in a lot of of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / projects is to answer specific human medical questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, like Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2). Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) Clinical Trials and other clinical trials allow for volunteers to have health treatment alternatives before they are available to the general public. Many times the test subjects obtain treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) clinical trial. Subjects oftentimes recieve the most effective healthcare possible for their Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) condition. Hazards are a reality, however, and could include additional or frequent doctor visits, healthcare dangers (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2)  Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2)
Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2)
For Condition: Pneumocystis carinii Infections,Cytomegalovirus Infections,Heart Diseases,Lung Diseases,HIV Infections,Ebstein-Barr virus infections,Cardiovascular Diseases,Heart Failure,Acquired Immunodeficiency Syndrome
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To determine the prevalence and natural history of pulmonary and cardiac complications associated with HIV infection in utero, in infancy, and during early childhood.
Details: BACKGROUND: In 1982, a year after the discovery of AIDS in adults, cases were described in children. Subsequent reports clearly indicated that pulmonary and cardiac diseases contributed significantly to morbidity and mortality in children infected with the human immunodeficiency virus. The initiative was developed by the staff of the Division of Lung Diseases and the Division of Heart and Vascular Diseases after consultation with members of the pulmonary, cardiology, and pediatric communities. The Request for Proposals was released in August 1988 and awards made in May 1989. DESIGN NARRATIVE: In this prospective natural history study, research was conducted on the response of the immature lung to Pneumocystis carinii and other opportunistic lung infections, as well as on the etiology and pathogenesis of lymphocytic pulmonary disorders. The types, incidence, course, outcome, and origin of cardiac disorders were also determined. In addition to the pulmonary and cardiovascular measurements, data on the effects of co-infection with other viruses, CMV and EBV, were obtained. Enrollment of participants began in May 1990 and continued through April 1993 in Group I and through January 1994 for Group II. The cohort was followed at specified intervals for an additional three years beyond the end of recruitment for clinical examination, cardiac, pulmonary, immunologic, and infectious studies and for intercurrent illnesses (The cohorts were followed through January 1997). Follow-up ranged from 2.5 to 6.6 years. The study ends in July 2002. Analysis of the database, preparation of manuscripts and follow-up of adult type pulmonary function studies in infants currently followed at sites conducting the Womens & Infants Transmission Study (WITS) continue through July 2002
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Male
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
SamuelKaplan, , University of California
Additional Information:
Study ID Numbers: 1301;
Study Start Date: May 1989
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005274
Other Heart Diseases Studies:
1. Psychophysiology of Cardiovascular Reactivity
2. Lipid Variability--Influence of Stress
3. Polyunsaturates and KCL to Control Mild Hypertension
4. NAS-NRC Twin Registry
5. Evaluation of Low Literacy CVD Nutrition Education
Related Studies:
Other Heart Diseases Clinical Trials
Other Clinical Trials
Other Clinical Trials
Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2)
|
|
|
|
|
|
|
|
